TH182343B - A stable pharmaceutical component against tuberculosis in the form of a flattened, dispersed tablet. It is comprised of isoniacid granules and rifapentene granules and their preparation processes. - Google Patents

A stable pharmaceutical component against tuberculosis in the form of a flattened, dispersed tablet. It is comprised of isoniacid granules and rifapentene granules and their preparation processes.

Info

Publication number
TH182343B
TH182343B TH1601000296A TH1601000296A TH182343B TH 182343 B TH182343 B TH 182343B TH 1601000296 A TH1601000296 A TH 1601000296A TH 1601000296 A TH1601000296 A TH 1601000296A TH 182343 B TH182343 B TH 182343B
Authority
TH
Thailand
Prior art keywords
granules
rifapentene
isoniacid
flattened
comprised
Prior art date
Application number
TH1601000296A
Other languages
Thai (th)
Other versions
TH1601000296A (en
Original Assignee
ซาโนฟี
Filing date
Publication date
Application filed by ซาโนฟี filed Critical ซาโนฟี
Publication of TH182343B publication Critical patent/TH182343B/en
Publication of TH1601000296A publication Critical patent/TH1601000296A/en

Links

Claims (1)

------23/11/2560------(OCR) หน้า 1 ของจำนวน 2 หน้า ข้อถือสิทธิ 1) องค์ประกอบของขนาดยาที่กำหนดทางเภสัชกรรมที่ให้ทางปากในรูปของยาเม็ดแบน ชนิดที่แตกตัวอย่างรวดเร็วสำหรับใช้ในการบำบัดวัณโรค องค์ประกอบทางเภสัชกรรมที่ให้ทางปาก ดังกล่าวซึ่งประกอบรวมด้วย a) แกรนูลซึ่งประกอบรวมด้วยไอโซไนอาซิด แกรนูล, b) แกรนูลซึ่งประกอบรวมด้วยไรฟาเพนทีน แกรนูล, และ c) อย่างน้อยหนึ่งกระสายยาภายนอกแกรนูล 2) องค์ประกอบทางเภสัชกรรมที่ให้ทางปากตามข้:------ 11/23/2017 ------ (OCR) Page 1 of Number 2 Page Disclaimer 1) Composition of the prescribed dose of pharmaceutical drug administered orally in flat tablet form. A rapidly branched type for use in the treatment of tuberculosis Pharmaceutical components given by mouth This includes a) granules containing isoniacid granules, b) granules containing rifapentene granules, and c). At least one external granulation solution 2) Oral pharmaceutical components as follows:
TH1601000296A 2014-07-22 Stable pharmaceutical composition against tuberculosis in the form of disintegrating tablets. rapidly comprising isoniazid granules and rifapentine granules and their preparation processes. TH1601000296A (en)

Publications (2)

Publication Number Publication Date
TH182343B true TH182343B (en) 2018-12-20
TH1601000296A TH1601000296A (en) 2018-12-20

Family

ID=

Similar Documents

Publication Publication Date Title
RU2018114447A (en) INTRODUCTION OF CFTER DUTERED AMPLIFIERS
EA201791702A1 (en) THERAPEUTIC TOOLS ON THE BASIS OF GLYCANS AND RELATED METHODS
JP2015057451A5 (en)
JP2016147915A5 (en)
NZ631100A (en) Soft chewable pharmaceutical products
CO2016003340A2 (en) Pharmaceutical formulations, processes for preparation and methods of use
RU2016131454A (en) APPLICATIONS OF VITAMIN D AND ITS COMPOSITIONS FOR ANTIBIOSIS
WO2016040462A3 (en) Formulations and methods for treatment of metabolic syndrome
HRP20161796T1 (en) Pharmaceutical composition for use in the treatment or prevention of vitamin and mineral deficiencies in patient which have been subjected to gastric bypass-surgery
CO2018014217A2 (en) Pharmaceutical compositions comprising safinamide
EA201691693A3 (en) COMBINED MEDICINE PREPARATION IN THE FORM OF SPELLING TABLETS AND METHOD OF ITS PREPARATION
PH12016500120A1 (en) Anti-tuberculosis stable pharmaceutical composition in a form of a coated tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation
SA516370446B1 (en) Anti-tuberculosis stable pharmaceutical composition in a form of a dispersible tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation
JP2016513680A5 (en)
WO2015011653A9 (en) pH RESPONSIVE ORAL POLYMERIC PHARMACEUTICAL DOSAGE FORM
MX2018003890A (en) Pharmaceutical compositions containing a muscle relaxant and a non-steroidal anti-inflammatory drug (nsaid).
TH182343B (en) A stable pharmaceutical component against tuberculosis in the form of a flattened, dispersed tablet. It is comprised of isoniacid granules and rifapentene granules and their preparation processes.
EA201791458A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DISEASES OF THE GASTROINTESTINAL TRACT
CO2018010142A2 (en) Mesalazine solid formula preparation process
UY37413A (en) OPROZOMIB IMMEDIATE RELEASE FORMULATIONS
HRP20160811T1 (en) Use of odiparcil in the treatment of mucopolysaccharidosis
WO2016020936A3 (en) A novel oral gastroretentive pharmaceutical dosage form
HRP20231197T1 (en) Use of tamoxifen for the treatment of cystic fibrosis in non-female patients
JP2017515849A5 (en)
EA201691763A1 (en) STABLE, QUICKLY SOLUBLE DOSE FORM, CONTAINING AMOXICILLIN AND STOPPING ACID